TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.

Nick Pavlakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.